Radiotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Radiotherapy, including details on cancer treatment, side effects.

Volume 1 (2004), Issue 5 (December)

1. Reduced-intensity conditioning using TBI (8 Gy), fludarabine, cyclophosphamide and ATG in elderly CML patients provides excellent results especially when performed in the early course of the disease.
   Bone Marrow Transplant, 34(12): 1083-8. [Abstract] [Full-text]
2. Prospective trial of intraoperative radiation treatment for breast cancer.
   ANZ J Surg, 74(12): 1043-8. [Abstract] [Full-text]
3. Neuropsychological change following gamma knife surgery in patients with left temporal lobe epilepsy: a review of three cases.
   Epilepsy Behav, 5(6): 949-57. [Abstract] [Full-text]
4. Targeting of HER2 antigen for the treatment of disseminated peritoneal disease.
   Clin Cancer Res, 10(23): 7834-41. [Abstract] [Full-text]
5. The radioisotope contributes significantly to the activity of radioimmunotherapy.
   Clin Cancer Res, 10(23): 7792-8. [Abstract] [Full-text]
6. Treatment parameters for beta and gamma devices in peripheral endovascular brachytherapy.
   Int J Radiat Oncol Biol Phys, 60(5): 1652-9. [Abstract] [Full-text]
7. Frameless image guidance improves accuracy in three-dimensional interstitial brachytherapy needle placement.
   Int J Radiat Oncol Biol Phys, 60(5): 1645-51. [Abstract] [Full-text]
8. The utility of megavoltage computed tomography images from a helical tomotherapy system for setup verification purposes.
   Int J Radiat Oncol Biol Phys, 60(5): 1639-44. [Abstract] [Full-text]
9. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
   Int J Radiat Oncol Biol Phys, 60(5): 1631-8. [Abstract] [Full-text]
10. Isocenter characteristics of an external ring proton gantry.
    Int J Radiat Oncol Biol Phys, 60(5): 1622-30. [Abstract] [Full-text]
11. Magnetic resonance assessment of prostate localization variability in intensity-modulated radiotherapy for prostate cancer.
    Int J Radiat Oncol Biol Phys, 60(5): 1611-21. [Abstract] [Full-text]
12. Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery.
    Int J Radiat Oncol Biol Phys, 60(5): 1602-10. [Abstract] [Full-text]
13. Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy.
    Int J Radiat Oncol Biol Phys, 60(5): 1589-601. [Abstract] [Full-text]
14. Target volume uncertainty and a method to visualize its effect on the target dose prescription.
    Int J Radiat Oncol Biol Phys, 60(5): 1580-8. [Abstract] [Full-text]
15. MR and CT image fusion for postimplant analysis in permanent prostate seed implants.
    Int J Radiat Oncol Biol Phys, 60(5): 1572-9. [Abstract] [Full-text]
16. Factors predicting local tumor control after gamma knife stereotactic radiosurgery for benign intracranial meningiomas.
    Int J Radiat Oncol Biol Phys, 60(5): 1515-9. [Abstract] [Full-text]
17. Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease.
    Int J Radiat Oncol Biol Phys, 60(5): 1502-9. [Abstract] [Full-text]
18. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
    Int J Radiat Oncol Biol Phys, 60(5): 1440-50. [Abstract] [Full-text]
19. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?
    Int J Radiat Oncol Biol Phys, 60(5): 1425-39. [Abstract] [Full-text]
20. Value of FDG PET in assessment of treatment response and surveillance in head-and-neck cancer patients after intensity modulated radiation treatment: a preliminary report.
    Int J Radiat Oncol Biol Phys, 60(5): 1410-8. [Abstract] [Full-text]
21. Biologic comparison of partial breast irradiation protocols.
    Int J Radiat Oncol Biol Phys, 60(5): 1393-404. [Abstract] [Full-text]
22. Radiation dose delivered to the proximal penis as a predictor of the risk of erectile dysfunction after three-dimensional conformal radiotherapy for localized prostate cancer.
    Int J Radiat Oncol Biol Phys, 60(5): 1357-63. [Abstract] [Full-text]
23. Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: findings from a prospective, multi-institutional, phase I/II dose-escalation study.
    Int J Radiat Oncol Biol Phys, 60(5): 1351-6. [Abstract] [Full-text]
24. Angiographic and clinical outcomes of late total occlusion versus treatment failure without late total occlusion in patients after intracoronary radiation therapy for in-stent restenosis.
    Am J Cardiol, 94(12): 1551-4. [Abstract] [Full-text]
25. Conformal radiotherapy of urinary bladder cancer.
    Radiother Oncol, 73(3): 387-98. [Abstract] [Full-text]
26. Verification of patient position and delivery of IMRT by electronic portal imaging.
    Radiother Oncol, 73(3): 339-47. [Abstract] [Full-text]
27. Influence of dose point and inverse optimization on interstitial cervical and oropharyngeal carcinoma brachytherapy.
    Radiother Oncol, 73(3): 331-7. [Abstract] [Full-text]
28. Analysis and evaluation of periodic physiological organ motion in radiotherapy treatments.
    Radiother Oncol, 73(3): 325-9. [Abstract] [Full-text]
29. Post-operative treatment of malignant salivary gland tumours of the palate with iodine-125 brachytherapy.
    Radiother Oncol, 73(3): 307-11. [Abstract] [Full-text]
30. The centenary of the discovery of the Bragg peak.
    Radiother Oncol, 73(3): 265-8. [Abstract] [Full-text]
31. Palifermin for oral mucositis after intensive therapy for hematologic cancers.
    N Engl J Med, 351(25): 2590-8. [Abstract] [Full-text]
32. Three-dimensional conformal radiotherapy in the treatment of prostate cancer in Australia and New Zealand: Report on a survey of radiotherapy centres and the proceedings of a consensus workshop.
    Australas Radiol, 48(4): 502-8. [Abstract] [Full-text]
33. Australian and New Zealand three-dimensional conformal radiation therapy consensus guidelines for prostate cancer.
    Australas Radiol, 48(4): 493-501. [Abstract] [Full-text]
34. Anaplastic (pleomorphic) subtype embryonal rhabdomyosarcoma of the cervix.
    Arch Gynecol Obstet, 270(4): 278-80. [Abstract] [Full-text]
35. The significance of tumor location for Gamma Knife treatment of meningiomas.
    Stereotact Funct Neurosurg, 82(4): 194-5. [Abstract] [Full-text]
36. Radiosurgical planning of meningiomas: compromises with conformity.
    Stereotact Funct Neurosurg, 82(4): 169-74. [Abstract] [Full-text]
37. Teleradiotherapy of joints in rheumatoid arthritis: lack of efficacy.
    Ann Rheum Dis, 64(1): 138-40. [Abstract] [Full-text]
38. Preparation and in vivo evaluation of novel linkers for 211At labeling of proteins.
    Nucl Med Biol, 31(8): 1061-71. [Abstract] [Full-text]
39. Formates and dithionates: sensitive EPR-dosimeter materials for radiation therapy.
    Appl Radiat Isot, 62(2): 317-24. [Abstract] [Full-text]
40. EPR study of radiation stability of organic plastic scintillator for cardiovascular brachytherapy Sr90-Y90 beta dosimetry.
    Appl Radiat Isot, 62(2): 301-6. [Abstract] [Full-text]
41. Use of alanine for dosimetry intercomparisons among Italian radiotherapy centers.
    Appl Radiat Isot, 62(2): 261-5. [Abstract] [Full-text]
42. Prostate-specific antigen relapse-free survival in patients with localized prostate cancer treated by brachytherapy.
    BJU Int, 94(9): 1235-8. [Abstract] [Full-text]
43. Two cases of stereotactic radiosurgical boost as an initial treatment for young nasopharyngeal cancer patients.
    Jpn J Clin Oncol, 34(11): 692-5. [Abstract] [Full-text]
44. Development of respiratory motion reduction device system (RMRDs) for radiotherapy in moving tumors.
    Jpn J Clin Oncol, 34(11): 686-91. [Abstract] [Full-text]
45. Rationale for chemoradiotherapy.
    Int J Clin Oncol, 9(6): 414-20. [Abstract] [Full-text]
46. Effects of probucol versus aspirin and versus brachytherapy on restenosis after femoropopliteal angioplasty: the PAB randomized multicenter trial.
    J Endovasc Ther, 11(6): 595-604. [Abstract] [Full-text]
47. Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration: a comparison with sugar permeability tests.
    Cancer, 103(1): 191-9. [Abstract] [Full-text]
48. Long-term results of high-dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix.
    Cancer, 103(1): 92-101. [Abstract] [Full-text]
49. A customized orofacial brachytherapy carrier: a clinical report.
    J Prosthet Dent, 93(1): 24-7. [Abstract] [Full-text]

© 2004-2008 Radiotherapy Research Today. All Rights Reserved.